| More from our friend Doc Gumshoe to share today -- he's got some thoughts about Alzheimer's Disease, hope, the controversial aducanumab approval, and where things are headed... Doc doesn't cover the investment side of these stories, but all of us who want to invest in the bright dollar signs that pop up whenever someone teases a company with an Alzheimer's drug surely ought to have some perspective on the disease... and we've pretty much all seen friends or family suffer, so a little hope goes a long way. Just click below for Michael's latest... |
